Kevin Patrick Moran - 29 Jul 2024 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
SVP, CFO & Treasurer
Signature
/s/ Kevin Patrick Moran
Issuer symbol
VNDA
Transactions as of
29 Jul 2024
Net transactions value
-$13,327
Form type
4
Filing time
29 Jul 2024, 17:24:41 UTC
Previous filing
06 Mar 2024
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNDA Common Stock Sale $13,327 -2,251 -0.97% $5.92 228,763 29 Jul 2024 Direct F1
holding VNDA Common Stock 635 29 Jul 2024 By Wife
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the default "same day sale" provisions of the RSU agreements.